Premium
Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis
Author(s) -
Koutsilieris Michael,
Dimopoulos Theodore,
Milathianakis Constantine,
Bogdanos John,
Karamanolakis Dimitrios,
Pissimissis Nicholas,
Halapas Antonis,
Lembessis Peter,
Papaioannou Andreas,
Sourla Antigone
Publication year - 2007
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2007.06958.x
Subject(s) - medicine , general hospital , prostate cancer , general surgery , cancer
Michael Koutsilieris, Theodore Dimopoulos*, Constantine Milathianakis†, John Bogdanos, Dimitrios Karamanolakis, Nicholas Pissimissis, Antonis Halapas, Peter Lembessis, Andreas Papaioannou‡ and Antigone Sourla¶ Department of Experimental Physiology, Medical School, National & Kapodistrian University of Athens, Goudi-Athens, *Urology Clinic, Panagia General Hospital, Thessaloniki, †Urology Clinic, ‘Metaxa’ Anticancer Hospital, Piraeus, ‡Urology Clinic, Argos General Hospital, Argos, and ¶Endo/OncoResearch Laboratories, Diagnostic Medical Center, Athens, Greece